TY - CHAP M1 - Book, Section TI - Pharmacotherapy of Psychosis and Mania A1 - Meyer, Jonathan M. A2 - Brunton, Laurence L. A2 - Hilal-Dandan, Randa A2 - Knollmann, Björn C. PY - 2017 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e AB - AbbreviationsACEI: angiotensin-converting enzyme inhibitorAUC: area under the curveCBC: complete blood cell countCNS: central nervous systemCOX-2: cyclooxygenase 2CV: cardiovascularDA: dopamineDAAO:D-amino acid oxidaseDAT: DA transporterDM: diabetes mellitusECG: electrocardiogramECT: electroconvulsive therapyeGFR: estimated glomerular filtration rateEM: extensive metabolizerENaC: epithelial sodium channelEPS: extrapyramidal symptomFDA: Food and Drug AdministrationG-CSF: granulocyte colony-stimulating factorGFR: glomerular filtration rateGlyT: glycine transporterGSK: glycogen synthase kinase5HT: serotoninIkr: inwardly rectifying K+ channelsIM: intramuscularLAI: long-acting injectableMAO: monoamine oxidasemGlu: metabotropic glutamateNDI: nephrogenic diabetes insipidusNE: norepinephrineNMDA:N-methyl-D-aspartateNMS: neuroleptic malignant syndromeODT: oral dissolving tabletPDP: Parkinson disease psychosisPET: positron emission tomographyPGP: P-glycoproteinPK_: protein kinase _, as in PKA, PKCPP2A: protein phosphatase 2ASCD: sudden cardiac deathT4: levorotatory thyroxineTD: tardive dyskinesiaTH: tyrosine hydroxylaseTSH: thyrotropin (previously thyroid-stimulating hormone)VMAT2: vesicular monoamine transporter 2 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1162535494 ER -